A Study to Examine APL-130277 in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2014-11-24
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy, tolerability and safety of
single treatments of APL-130277 in 16 patients with Parkinson's Disease (PD)